These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 18300322)

  • 21. Quantification of analgesic use in children with sickle cell disease.
    Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
    Clin J Pain; 2007 Jan; 23(1):8-14. PubMed ID: 17277639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and implementation of an inpatient disease management program.
    Cooper GS; Armitage KB; Ashar B; Costantini O; Creighton FA; Raiz P; Wong RC; Carlson MD
    Am J Manag Care; 2000 Jul; 6(7):793-801. PubMed ID: 11067376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Admission and length of stay due to painful vasoocclusive crisis in children.
    Rogovik AL; Li Y; Kirby MA; Friedman JN; Goldman RD
    Am J Emerg Med; 2009 Sep; 27(7):797-801. PubMed ID: 19683107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study.
    Finkelstein Y; Schechter T; Garcia-Bournissen F; Kirby M; Nurmohamed L; Juurlink DN; Blanchette V; Koren G
    Clin Ther; 2007 Dec; 29(12):2738-43. PubMed ID: 18201591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mental health disorders influence admission rates for pain in children with sickle cell disease.
    Myrvik MP; Burks LM; Hoffman RG; Dasgupta M; Panepinto JA
    Pediatr Blood Cancer; 2013 Jul; 60(7):1211-4. PubMed ID: 23151972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inpatient care in a community hospital: comparing length of stay and costs among teaching, hospitalist, and community services.
    Carek PJ; Boggan H; Mainous AG; Geesey ME; Dickerson L; Laird S
    Fam Med; 2008 Feb; 40(2):119-24. PubMed ID: 18247178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Day case management of sickle pain: 3 years experience in a UK sickle cell unit.
    Wright J; Bareford D; Wright C; Augustine G; Olley K; Musamadi L; Dhanda C; Knight C
    Br J Haematol; 2004 Sep; 126(6):878-80. PubMed ID: 15352993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are there phases to the vaso-occlusive painful episode in sickle cell disease?
    Jacob E; Beyer JE; Miaskowski C; Savedra M; Treadwell M; Styles L
    J Pain Symptom Manage; 2005 Apr; 29(4):392-400. PubMed ID: 15857743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pilot study on the efficacy of ketorolac plus tramadol infusion combined with erythrocytapheresis in the management of acute severe vaso-occlusive crises and sickle cell pain.
    de Franceschi L; Finco G; Vassanelli A; Zaia B; Ischia S; Corrocher R
    Haematologica; 2004 Nov; 89(11):1389-91. PubMed ID: 15531461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of a hospitalist system on length of stay and cost for children with common conditions.
    Srivastava R; Landrigan CP; Ross-Degnan D; Soumerai SB; Homer CJ; Goldmann DA; Muret-Wagstaff S
    Pediatrics; 2007 Aug; 120(2):267-74. PubMed ID: 17671051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A clinical pathway for pelvic inflammatory disease for use on an inpatient service.
    Rome ES; Moszczenski SA; Craighill M; Goldmann DA; Schubert PS; Laufer MR; Emans SJ; Woods ER
    Clin Perform Qual Health Care; 1995; 3(4):185-96. PubMed ID: 10156936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benchmarking and reducing length of stay in Dutch hospitals.
    Borghans I; Heijink R; Kool T; Lagoe RJ; Westert GP
    BMC Health Serv Res; 2008 Oct; 8():220. PubMed ID: 18950476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Timing of opioid administration as a quality indicator for pain crises in sickle cell disease.
    Mathias MD; McCavit TL
    Pediatrics; 2015 Mar; 135(3):475-82. PubMed ID: 25667245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of magnesium on length of stay for pediatric sickle cell pain crisis.
    Brousseau DC; Scott JP; Hillery CA; Panepinto JA
    Acad Emerg Med; 2004 Sep; 11(9):968-72. PubMed ID: 15347549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in illness severity and length of stay in inner-city adolescents hospitalized for pelvic inflammatory disease.
    Kaul P; Stevens-Simon C; Saproo A; Coupey SM
    J Pediatr Adolesc Gynecol; 2008 Oct; 21(5):289-93. PubMed ID: 18794025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of psychiatric diagnoses on hospital length of stay in children with sickle cell anemia.
    Myrvik MP; Campbell AD; Davis MM; Butcher JL
    Pediatr Blood Cancer; 2012 Feb; 58(2):239-43. PubMed ID: 21425450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
    Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vaso-occlusive pain crises in children with sickle cell anemia].
    Fournier-Charrière E
    Soins Pediatr Pueric; 2007 Feb; (234):21-6. PubMed ID: 17338413
    [No Abstract]   [Full Text] [Related]  

  • 39. Laparoscopic cholecystectomy in children with sickle cell disease.
    Hatley RM; Crist D; Howell CG; Herline AJ; Gadacz TR
    Am Surg; 1995 Feb; 61(2):169-71. PubMed ID: 7856980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The presentation and management of the acute abdomen in the patient with sickle-cell anemia.
    Baumgartner F; Klein S
    Am Surg; 1989 Nov; 55(11):660-4. PubMed ID: 2817619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.